Increased risk of development of malignancies in adult patients treated with antithymocyte globulin as first line treatment for aplastic anaemia during a follow-up period of thirty years
Author(s):
Hem, J.V.D.; Wreede, L.D.; Brand, A.; Veelken, H.; Falkenburg, F.; Halkes, C.
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-03-31
Language
English
Is part of
Bone Marrow Transplantation (2015), Vol. 50, p. S86-S86
